Geron Statistics
NASDAQ: GERNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.22+0.02 (+1.67%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 1.22 0.00%
Geron by the numbers
Geron has a market capitalization of $783.8 million based on 642.47M shares outstanding. With trailing EPS of $-0.11, Geron is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.3% below its 50-day average and 15.5% below its 200-day average.
Average daily trading volume is 10.09M shares, or about $12.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GERN valuation vs. peer median
| Metric | GERN | Peer median | Difference |
|---|---|---|---|
| Market cap | $783.82M | $764.34M | +3% |
| Avg. volume | 10.09M | 1.71M | +489% |
Peer median across 8 companies: IMMX, LXRX, HELP, APMD, ANNX, IVA, OBX, VSTM.
Valuation
- Market cap
- $783.82M
- Forward P/E
- 30.50
- EPS (TTM)
- $-0.11
- Shares outstanding
- 642.47M
Price and trading
- Previous close
- 1.20
- Open
- 1.19
- Day range
- 1.17 – 1.22
- 52-week range
- 1.04 – 2.01
- 52-week change
- -6.98%
- Beta
- —
- Volume
- 10.16M
- Average volume
- 10.09M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 783.82M
- Forward Pe
- 30.50
- Eps
- -0.11
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.01
- Week52 Low
- 1.04
- Avg Volume
- 10.09M
- Shares Outstanding
- 642.47M
- Ma50
- 1.41
- Ma200
- 1.44
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -39.30%
- Pct From52w Low
- 17.31%